Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion type Assertion NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_head.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion wasGeneratedBy ECO_0000203 NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_provenance.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion wasDerivedFrom befree-20140225 NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_provenance.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion SIO_000772 19470724 NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_provenance.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion evidence source_evidence_literature NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_provenance.
- NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_assertion description "[Novel PLK, CENPE, and AURKB inhibitors should be assessed for therapeutic utility in poor prognosis cyclin B1-overexpressing breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860091.RA0AA7a0SPYibjH2rClN12rqDeQVsqMtFQPAhY_mB0-Pw130_provenance.